Skip to main content
OpenTrials
Completed

NCT Number: NCT07134868

Sepsis and Thiol-Disulfide Balance in Emergency Department

The aim of this study was to determine the effectiveness of thiol-disulfide homeostasis in predicting diagnosis and mortality in sepsis patients, and to compare it with other inflammatory markers.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Sakarya University

Sakarya, Adapazarı, 54050, Turkey (Türkiye)

About this study

Sepsis is a serious illness with high mortality rates triggered by infection-associated pathogenesis involving oxidative stress dysfunction. This study aims to elucidate the diagnostic efficacy of changes in thiol-disulfide homeostasis, its predictive role in mortality, relationship with other inflammatory parameters in sepsis patients in emergency department.

In prospective, randomized controlled study, 50 patients diagnosed with sepsis according to the Sepsis-3 guidelines who presented emergency department were compared with a control group of 50 healthy volunteers. Thiol-disulfide homeostasis parameters, including total thiol, native thiol, disulfide levels, reduced thiol, oxidized thiol, and thiol oxidation-reduction ratios, were examined. Additionally, inflammatory blood parameters (C-reactive protein, procalcitonin, lactate) and mortality durations were compared with thiol-disulfide homeostasis.

The objective of this study was to examine the effectiveness of thiol-disulfide homeostasis in forecasting diagnosis and mortality in sepsis patients, and to compare it against other inflammatory markers.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Patients aged 18 and above who met the diagnostic criteria were included in the study

Exclusion criteria

  • Who did not meet the criteria for sepsis diagnosis according to the quick Sequential Organ Failure Assessment score
  • Individuals with malignancy, acute coronary syndrome, acute cerebrovascular event, acute/chronic kidney/liver failure, rheumatologic diseases, febrile neutropenia, immunosuppressive disorders, corticosteroid use, and those
  • Individuals with a history of antibiotic use within the last week

Treatment and study plan

Thiol- Disulfide Blood Sample Measurement

Diagnostic Test

Measurement of thiol-disulfide homeostasis parameters and inflammatory markers from serum samples.

Primary outcomes

  1. Diagnostic value of serum thiol-disulfide homeostasis parameters in sepsis

    Time frame: 2 monhts

    Measurement of serum total thiol, native thiol, disulfide, reduced thiol, and oxidized thiol levels in patients with sepsis and healthy controls at the time of admission, and comparison between groups to evaluate diagnostic performance.

Secondary outcomes

  1. General Characteristics of All Participants

    Time frame: 1 week

    Demographic data (age, gender, body mass index) were recorded.

  2. Correlation of inflammatory and biochemical markers with thiol-disulfide homeostasis in sepsis

    Time frame: 10 days

    Initial blood samples collected from sepsis patients were analyzed to measure total thiol, native thiol, disulfide, reduced thiol, and oxidized thiol levels. These thiol-disulfide homeostasis parameters were then compared and correlated with standard laboratory inflammatory markers, including C-reactive protein (CRP), procalcitonin, and lactate, to evaluate their relationships.

Sponsors and collaborators

Lead sponsor

Sakarya University

Other

Registry information

Official study title

The Diagnostic Efficacy of Thiol-Disulfide Homeostasis in Sepsis Patients

Important dates

Study start
2018
Primary completion
2018
Study completion
2018
First posted
Aug 21, 2025
Registry last updated
Aug 21, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.